11 July, 2022
in News
06 October, 2021
in News
New indications in oncology not easily accessible to French patients
19 March, 2021
in News
UK Cancer Drugs Fund to be expanded for non-cancer therapies
25 February, 2021
in News
Japan’s First Pricing Reform Since 2013, expected in April 2021
10 February, 2021
in News
Cost-effectiveness and budget impact to be included in new IPTs
20 January, 2021
in News
Innovative CAR-T cell therapy set to be reimbursed by NICE
14 January, 2021
in News
New routes to marketing approval in Great Britain
08 January, 2021
in News
Best wishes from Prioritis
12 February, 2020
in News
EMA after Brexit? Prioritis continues to monitor the changes
22 October, 2019
in News